Cerebral cortical lesions were produced using a stereotactic injection
system in Sprague-Dawley rats randomly assigned to three groups: (1)
needle lesioned and uninjected (Lesioned), (2) needle lesion and simul
taneous local injection of 50 or 100 mu l 0.9% saline (L/Saline), and
(3) needle lesion and simultaneous local injection of 50 or 100 mu l V
erapamil-HCl (VHCL) (2.5 mg/ml (5 mM) Abbott Labs, Chicago, IL), a pas
sive, L-type calcium channel blocker (L/VHCL). The lesioning induced e
xpression of glial fibrillary acidic protein (GFAP), a type of interme
diate filament protein expressed in reactive astrocytes, at the lesion
site. There was a reduction in GFAP-Like immunoreactivity (GFAP-IR) i
n the L/VHCL group versus the Lesioned and the L/Saline groups. There
was a five-fold increase of GFAP-IR at 24 h post lesion in the L/Salin
e group, but no statistically significant increase seen in the Lesione
d or L/VHCL groups at either volume. Pretreatment of the anti-GFAP wit
h VHCL did not impair the antigen labeling. To determine whether diffe
rences in pHs, or volume could account for these findings, a second ex
periment was performed using pa-matched saline or VHCL in 10 mu l volu
me injected into contralateral hemispheres at the time of lesioning. T
here was an 80% reduction in GFAP-IR in the L/VHCL group at 72 h compa
red with the L/Saline group. These data suggest that VHCL may suppress
the early increase of GFAP-IR in response to cortical lesion and that
reducing transmembrane calcium flux through L-type calcium channels m
ay be the mechanism involved.